Author:
R Manasa,Johnson Aksa,Augustine Presly Thomas,Tom Anjana
Abstract
Purpose: The objective is to determine the predictors of hyperkalaemia, severity of hyperkalaemia and to access the prevalence of cardiovascular diseases
Methodology: A cross sectional observational study was conducted on the predictors of hyperkalaemia in CVD patients, in a tertiary care teaching hospital for a period of 6 months.
Results: Among 105 patients, there were 83 males and 22 females, the age group from 41-60 year shows more CVDs and 61-80 years aged patients are more prone to hyperkalaemia and shows more prevalent when compared to other age groups. The major risk factors of hyperkalaemia were Drugs (30.23%), Disease (58.13%), and Drug interactions (11.62%).Among the cardiovascular diseases, Myocardial Infarction (38%) were the most common type of CVD, while in hyperkalaemia Ischemic Heart Disease (48.83%) were more prevalent. The severity of hyperkalaemia is measured as Mild (60.46%), Moderate (37.20%), and Severe (2.32%).
Conclusion: The present study was carried out in order to assess the predictors, prevalence and severity of hyperkalaemia in cardiovascular disease patients. Our study concluded that patients with cardiovascular disease can have an increased risk of hyperkalaemia.
Keywords: CVD, Hyperkalaemia, Cross sectional observational study, Predictors, Prevalence, Severity.
Publisher
Society of Pharmaceutical Tecnocrats
Reference24 articles.
1. 1. Aiswarya A T, et al. A Study on the Assessment of Risk Factors and Evaluation of Prescribing Pattern in Patients with Hyperkalemia Having Cardiovascular Disorders", International journal of pharmacy and pharmaceutical research,vol 2018; 11(4)
2. 2 Núñez Julio et al. "Long-Term Potassium Monitoring And Dynamics In Heart Failure And Risk Of Mortality". Circulation, 2018; 137(13):1320-1330. Ovid Technologies (Wolters Kluwer Health), doi:10.1161/circulationaha.117.030576.
3. 3. High potassium (hyperkalemia) [Internet] 2018 Jan 11. Available form: https://www.mayoclinic.org/symptoms/hyperkalemia/basics/definition/sym-20050776
4. 4. Alldredge B, Koda-Kimble M, Young L. Applied therapeutics. Philadelphia, Pa.: Wolters Kluwer / Lippincott Williams & Wilkins; 2013
5. 5. Michel Alexander et al. "Risk Factors For Hyperkalaemia In A Cohort Of Patients With Newly Diagnosed Heart Failure: A Nested Case-Control Study In UK General Practice". European Journal Of -9-Heart Failure, 2015; 17(2):205-213. Wiley, doi:10.1002/ejhf.226.